Scopio Labs, a Tel Aviv medical technology company, has received approval from the U.S. Food and Drug Administration (FDA) for new features in its digital blood testing system.

This marks the company’s fourth FDA clearance and brings advanced artificial intelligence tools to hospitals and labs across the United States.

The upgraded system helps doctors and lab technicians analyze blood samples more quickly and accurately.